glp 1 drugs how long have they been around GLP-1s were first approved in 2005 for the treatment of type 2 diabetes. Over the past two decades, more versions of the medication hit the market, becoming more accessible to patients The expanding landscape of GLP-1

Benefits of GLP-1 for Weight Management GLP-1-based treatments may support weight management goals when used as part of a supervised wellness plan

Muscle mass preservation is an important consideration given the risk of sarcopenic obesity: weight loss with GLP-1 RAs includes a lean mass component (approximately 25%-40% of total weight loss), though the clinical significance in MASLD patients without sarcopenia is uncertain

Most respondents (62%) who have ever taken a GLP-1 drug say they took the drugs to treat a chronic condition such as diabetes or heart disease

( (Accessed 6/1/2025) What sets apart the adverse events reported with compounded versions is the concern over manufacturing variability and dosing inconsistency, not necessarily a higher number of events, but the increased uncertainty in product quality and composition

doi: 10.1002/anr3.12278

Papakonstantinou T, Nikolakopoulou A, Higgins JPT, Egger M, Salanti G